Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Jianqun Liao
Introduction
Jianqun Liao is a prominent inventor based in Buffalo, NY (US). He has made significant strides in the field of cancer treatment through his innovative work on anticancer drugs. His dedication to research and development has led to the creation of novel formulations aimed at combating cancer.
Latest Patents
Jianqun Liao holds a patent for an anticancer drug formulation known as FL118. This formulation is designed for the treatment of human cancer and aims to preclude, eliminate, or reverse cancer phenotypes and treatment resistance. His work in this area is crucial for advancing cancer therapies and improving patient outcomes.
Career Highlights
Liao is associated with Canget Biotek Pharma LLC, where he continues to contribute to groundbreaking research in pharmaceuticals. His expertise and innovative approach have positioned him as a key figure in the development of effective cancer treatments.
Collaborations
Jianqun Liao collaborates with notable colleagues, including Fengzhi Li and Xiang Ling. Their combined efforts enhance the research and development process, leading to more effective solutions in the fight against cancer.
Conclusion
Jianqun Liao's contributions to cancer treatment through his innovative formulations exemplify the impact of dedicated research in the medical field. His work not only advances scientific knowledge but also holds the potential to improve the lives of countless individuals affected by cancer.